Clinical Trials Directory

Trials / Completed

CompletedNCT04103710

Prevalence of Molar Incisor Hypomineralization Among Children Treated With Asthmatic Drugs Early in Their Lives

Prevalence of Molar Incisor Hypo Mineralization Among Children Who Have Been Treated With Asthmatic Drugs During Their First Three Years of Life(A Cross- Sectional Study)

Status
Completed
Phase
Study type
Observational
Enrollment
167 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to assess the prevalence of molar incisor hypo mineralization among children who have been treated with asthmatic drugs during the first three years of life.

Detailed description

The term Molar incisor hypo mineralization (MIH) was first introduced in 2001 as a developmental disorder of enamel characterized by hypo mineralization -of systemic origin - affecting the enamel of first permanent molars (PFM) ,frequently associated with affected permanent incisors. The prevalence of MIH varies widely, ranging from 2.4 % to 40.2% in different populations. This wide variation may be due to differences in diagnostic criteria and methodologies used by the authors. Concerning the etiology of MIH it is mostly related to pre natal, perinatal, and post natal illness. Asthma and asthmatic drugs have been proposed to be one of the etiological factors of MIH,Internationally, the mean prevalence of pediatric asthma is 10%.

Conditions

Timeline

Start date
2020-05-20
Primary completion
2022-05-01
Completion
2022-07-01
First posted
2019-09-25
Last updated
2023-09-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04103710. Inclusion in this directory is not an endorsement.